Company Profile

Nal Pharma Is A Specialty Drug Developer That Develops Novel Dosage Forms And Proprietary Drug Delivery Systems Based On The Company S Captive Bio D3Bio Fxbio Crbio Nnand Bio Mm Drug Delivery System Dds Technologiesheadquartered In Hong Kong And With Operation In The United Statesnal Is Developing Non Infringingproprietary And Improved Drug Delivery Systems That Exhibit Enhanced Patient Compliancesafetyand Or Efficacy Compared With Existing Pharmaceutical Productsand Is Also Developing Specially Designed Delivery Systems To Improve Conventional Dosage Forms Of New Drugs Undergoing Phase 2 Clinical Development That Show Significant First Pass Metabolism Side Effectspoor Solubilityand Poor Bioavailability As The Us Operation Of Nalgalaxy Bioincgbi Ae Has Established A Captive R&D Laboratory In Princetonnew Jerseyusa For The Development Of Afore Mentioned Nal S Innovative And Proprietary Dds Productscombining Established Product Formulation And Manufacturing Development Expertisenal Has Developed A Number Of Non Infringingproprietary And Improved Therapeutic Products That Incorporate Patent Expiring Drugsnal Is Working With Major Consumer Healthcare Companies To Extend The Life Cycle Of Patent Expiring Drugs For The Rx To Otc Switchnal Is Also Working With Major Pharmaceutical Companies To Improve The Formulations Of Their Nce Drugs Under Developmentin An Effort To Develop The Most Effective Delivery Systems Based On Nal S Proprietary Dds Technologies